Analysis of the GeneXpert System on the International Multicentre ICORG 08-02 Phase II Study of Nilotinib 300mg BID as Frontline Treatment in Patients with Early Chronic Phase Chronic Myeloid Leukemia (ECPCML)

M.E. O'Dwyer; R. Swords; F. Giles; Mary Frances McMullin; P.D. Le Coutre; A. Nagler; S. Langabeer; M. Wieczorkowska; C. McDowell; K. Egan; B. Moulton; E. Conneally

Analysis of the GeneXpert System on the International Multicentre ICORG 08-02 Phase II Study of Nilotinib 300mg BID as Frontline Treatment in Patients with Early Chronic Phase Chronic Myeloid Leukemia (ECPCML)

M.E. O'Dwyer
, R. Swords
, F. Giles
, Mary Frances McMullin
, P.D. Le Coutre
, A. Nagler
, S. Langabeer
, M. Wieczorkowska
, C. McDowell
, K. Egan
, B. Moulton
, E. Conneally

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	1612-1613
Number of pages	2
Journal	Blood
Volume	118
Publication status	Published - Dec 2011

Cite this

O'Dwyer, M. E., Swords, R., Giles, F., McMullin, M. F., Le Coutre, P. D., Nagler, A., Langabeer, S., Wieczorkowska, M., McDowell, C., Egan, K., Moulton, B., & Conneally, E. (2011). Analysis of the GeneXpert System on the International Multicentre ICORG 08-02 Phase II Study of Nilotinib 300mg BID as Frontline Treatment in Patients with Early Chronic Phase Chronic Myeloid Leukemia (ECPCML). Blood, 118, 1612-1613.

@article{b2acf3ee2e2445c0a437b37c0b8843b5,

title = "Analysis of the GeneXpert System on the International Multicentre ICORG 08-02 Phase II Study of Nilotinib 300mg BID as Frontline Treatment in Patients with Early Chronic Phase Chronic Myeloid Leukemia (ECPCML)",

author = "M.E. O'Dwyer and R. Swords and F. Giles and McMullin, \{Mary Frances\} and \{Le Coutre\}, P.D. and A. Nagler and S. Langabeer and M. Wieczorkowska and C. McDowell and K. Egan and B. Moulton and E. Conneally",

year = "2011",

month = dec,

language = "English",

volume = "118",

pages = "1612--1613",

journal = "Blood",

issn = "0006-4971",

publisher = "Elsevier B.V.",

}

O'Dwyer, ME, Swords, R, Giles, F, McMullin, MF, Le Coutre, PD, Nagler, A, Langabeer, S, Wieczorkowska, M, McDowell, C, Egan, K, Moulton, B & Conneally, E 2011, 'Analysis of the GeneXpert System on the International Multicentre ICORG 08-02 Phase II Study of Nilotinib 300mg BID as Frontline Treatment in Patients with Early Chronic Phase Chronic Myeloid Leukemia (ECPCML)', Blood, vol. 118, pp. 1612-1613.

TY - JOUR

T1 - Analysis of the GeneXpert System on the International Multicentre ICORG 08-02 Phase II Study of Nilotinib 300mg BID as Frontline Treatment in Patients with Early Chronic Phase Chronic Myeloid Leukemia (ECPCML)

AU - O'Dwyer, M.E.

AU - Swords, R.

AU - Giles, F.

AU - McMullin, Mary Frances

AU - Le Coutre, P.D.

AU - Nagler, A.

AU - Langabeer, S.

AU - Wieczorkowska, M.

AU - McDowell, C.

AU - Egan, K.

AU - Moulton, B.

AU - Conneally, E.

PY - 2011/12

Y1 - 2011/12

M3 - Article

SN - 0006-4971

VL - 118

SP - 1612

EP - 1613

JO - Blood

JF - Blood

ER -